Correlation analysis of the systemic immune-inflammation index with preoperative lower extremity deep venous thrombosis in patients with tibial fractures

胫骨骨折患者术前下肢深静脉血栓形成与全身免疫炎症指数的相关性分析

阅读:1

Abstract

OBJECTIVES: This study aimed to explore the risk factors for preoperative lower extremity Deep Vein Thrombosis (DVT) in patients with tibial fractures, analyze the correlation and predictive value of Systemic Immune-Inflammation Index in DVT. METHODS: This study retrospectively analyzed the preoperative clinical data of 366 patients with tibial fractures from 15/05/2022 to 15/04/2025.All patients underwent lower extremity venous ultrasound exam ination upon admission and before surgery to confirm the occurrence of deep vein thrombosis (DVT), divided into the DVT group and the non-DVT group. Univariate analysis was performed on the data of the two groups, and variables with statistical differences in the univariate analysis were subjected to binary Logistic regression analysis to explore the risk factors for lower extremity DVT. Variables with statistical significance identified by multivariate logistic regression analysis were used to construct a risk prediction model. RESULTS: Among the 366 patients with tibial fractures, 74 developed thrombosis, with a DVT incidence rate of 20.2%.Binary Logistic regression analysis showed that Age > 40.5 years (OR = 5.784,95% CI 2.454–13.631), SII > 858.5(OR = 5.167,95% CI 2.136–12.495), D-dimer > 1.36 mg/L (OR = 3.179,95% CI 1.619–6.269)were independent risk factors for preoperative DVT in patients with tibial fractures (P < 0.05). The DVT prediction risk model showed an AUC of 0.872 (95%CI, 0.831 to 0.913), with a sensitivity of 0.878 and a specifcity of 0.701. CONCLUSION: The incidence of DVT is relatively high in patients with tibial fractures, Age > 40.5 years, SII > 858.5, D-dimer > 1.36 mg/L are high-risk factors for DVT in patients with tibial fractures. Clinically, attention should be paid to the relevant examination results of patients with the above factors, and timely prevention and treatment should be carried out.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。